Increasingly, atypical forms of HUS (aHUS) are recognized to result from disorders of complement regulation, including antibodies to or mutations in the genes encoding complement factors B, H, and I as well as cell surface marker CD46, complement component 3 (C3), and thrombomodulin [4]. The gene discussed is C3; the disease is atypical hemolytic-uremic syndrome.